An analysis of the national Surveillance, Epidemiology, and End Results (SEER) database sheds light on the clinical presentation and outcomes of patients with alveolar soft part sarcoma (ASPS), a rare soft tissue sarcoma that accounts for 1% of this class of cancers (J Surg Oncol 2016 Jan 25. [Epub ahead of print], PMID: 26804150).
Researchers at Harvard Medical School and Massachusetts General Hospital, both in Boston, studied data from SEER spanning a 40-year period, and identified